The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo-Reference-Cited by-同舟云学术

The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo

Published:2016-09 Issue:40 Volume:34 Page:4763-4770
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pedroza-Roldán César,Guapillo Carolina,Barrios-Payán Jorge,Mata-Espinosa Dulce,Aceves-Sánchez Michel de Jesús,Marquina-Castillo Brenda,Hernández-Pando Rogelio,Flores-Valdez Mario Alberto

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Protection by novel vaccine candidates, Mycobacterium tuberculosis DeltamosR and DeltaechA7, against challenge with a Mycobacterium tuberculosis Beijing strain;Marcus;Vaccine,2015

2. Prospects in Mycobacterium bovis Bacille Calmette et Guerin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?;Moliva;Vaccine,2015

3. Tuberculosis vaccine development: shifting focus amid increasing development challenges;Graves;Hum Vaccines Immunother,2015

4. Current efforts and future prospects in the development of live mycobacteria as vaccines;Ng;Expert Rev Vaccines,2015

5. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis;Sun;Vaccine,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hosts;Vaccine;2024-10

2. Mycobacterium tuberculosis Biofilms: Immune Responses, Role in TB Pathology, and Potential Treatment;ImmunoTargets and Therapy;2024-07

3. Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria;Vaccines;2024-05-12

4. Proteome and immunogenicity differences in BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c during planktonic growth in 7H9 and Proskauer Beck media;Tuberculosis;2024-01

5. BCG∆BCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice;Vaccine;2023-06